Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
Dr. Martha Boeckenfeld, CEO and Founder of the Marthaverse, posted on LinkedIn:
“A 17-year-old mixed algae in a small lab hidden on his grandfather’s Hudson Valley vineyard.
It grabbed wet tissue and wouldn’t let go.
That experiment turned into VetiGel: a plant-based gel that seals wounds and helps blood clot.
Trauma care’s hard problem:
Severe bleeding is the leading cause of preventable trauma death.
A major arterial bleed can kill in 3–5 minutes.
Most products need firm pressure, the right wound shape, and time.
Deep, jagged wounds are tough to pack.
What Joe built:
- A gel that seals fast and triggers clotting
- No manual pressure
- Stops bleeding in under 20 seconds
Works on skin and organs
The proof: In veterinary surgery on 16 dogs, VetiGel cut blood loss from 78 mL to 6.7 mL. Time to hemostasis dropped from 25 minutes to under 2.
Cresilon later created TraumaGel for humans. It’s FDA cleared.
It made Time’s “Best Inventions of 2025.”
The Department of Defense signed on.
Picture an earthquake. A mother pinned under rubble, bleeding from a deep wound. No ambulance for 40 minutes. A responder applies gel. The bleeding stops.
She’s still alive when rescue arrives.
We spent decades accepting some bleeds are too fast and too deep to stop in time. A kid in a vineyard lab didn’t accept that.
Follow me, Dr. Martha Boeckenfeld, for stories where curiosity changes medicine.
Share if you think big medical advances can start everywhere. We just need imagination!
This is my find for YOU on the the last Day of 2025 to show, how human imagination is saving lives!”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine